Gara Jalqabaatti › Kansara Qara'a Non-Small Cell › New Jersey › Edison
Qorannoo klinikaalii Kansara Qara'a Non-Small Cell Edison, NJ keessatti
Qorannoo 47 Kansara Qara'a Non-Small Cell f Edison fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 2
- Astera Cancer Care /ID# 272359, East Brunswick · Miili 6 fagaatti
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2/3
- Astera Cancer Care /ID# 277570, East Brunswick · Miili 6 fagaatti
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Namoota walitti qabaa jiraSadarkaa 1/2
- Astera Cancer Care /ID# 271915, East Brunswick · Miili 6 fagaatti
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- START New Jersey, East Brunswick · Miili 6 fagaatti
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Namoota walitti qabaa jiraSadarkaa 2
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · Miili 15 fagaatti
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Exelixis Clinical Site #88, East Brunswick · Miili 6 fagaatti
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2
- START New Jersey, East Brunswick · Miili 6 fagaatti
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Namoota walitti qabaa jiraSadarkaa 1
- Research Site, New Brunswick · Miili 3 fagaatti
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2/3
- Astera Cancer Care, East Brunswick · Miili 6 fagaatti
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Namoota walitti qabaa jiraSadarkaa 3
- Clinical Study Site, New Brunswick · Miili 3 fagaatti
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
Namoota walitti qabaa jiraSadarkaa 3
- Astera Cancer Care, Edison
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Namoota walitti qabaa jiraSadarkaa 2/3
- Local Institution - 007-975-A, Somerset · Miili 4 fagaatti
- Local Institution - 007-975-B, Somerset · Miili 4 fagaatti
- Local Institution - 007-975-C, Somerset · Miili 4 fagaatti
- fi 2 dabalataa
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · Miili 15 fagaatti
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
Namoota walitti qabaa jiraSadarkaa 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · Miili 15 fagaatti
Using Urine Samples to Identify Lung Cancer
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · Miili 15 fagaatti
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Namoota walitti qabaa jiraQorannoo ilaalaa
- Astera Cancer Care, East Brunswick · Miili 6 fagaatti
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Namoota walitti qabaa jiraSadarkaa 1/2
- START New Jersey East Brunswick, East Brunswick · Miili 6 fagaatti
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
Namoota walitti qabaa jiraSadarkaa 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · Miili 15 fagaatti
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
Namoota walitti qabaa jiraSadarkaa 1
- Site 104 - START New Jersey, East Brunswick · Miili 6 fagaatti
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Namoota walitti qabaa jiraSadarkaa 1
- Rutgers Cancer Institute, New Brunswick · Miili 3 fagaatti
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Namoota walitti qabaa jiraSadarkaa 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Namoota walitti qabaa jira
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · Miili 15 fagaatti
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Astera Cancer Care, East Brunswick · Miili 6 fagaatti
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Namoota walitti qabaa jiraSadarkaa 3
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · Miili 15 fagaatti
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
Namoota walitti qabaa jiraSadarkaa 2
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · Miili 15 fagaatti
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · Miili 15 fagaatti
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge · Miili 15 fagaatti
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- START Astera, LLC, East Brunswick · Miili 6 fagaatti
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Virtua Voorhees, Voorhees Township · Miili 5 fagaatti
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · Miili 15 fagaatti
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 2
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · Miili 15 fagaatti
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Virtua Voorhees, Voorhees Township · Miili 5 fagaatti
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2/3
- Virtua Voorhees, Voorhees Township · Miili 5 fagaatti
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
Namoota walitti qabaa jiraSadarkaa 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · Miili 3 fagaatti
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Virtua Voorhees, Voorhees Township · Miili 5 fagaatti
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · Miili 15 fagaatti
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · Miili 15 fagaatti
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · Miili 15 fagaatti
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Namoota walitti qabaa jiraSadarkaa 2
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · Miili 15 fagaatti
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · Miili 15 fagaatti
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- START, Astera, East Brunswick · Miili 6 fagaatti
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, New Brunswick · Miili 3 fagaatti
Qorannoo Kansara Qara'a Non-Small Cell magaalota biroo keessatti
- Houston, TXQorannoo 145
- New York City, NYQorannoo 121
- Arlington, VAQorannoo 104
- Nashville, TNQorannoo 97
- Boston, MAQorannoo 90
- Los Angeles, CAQorannoo 87
- St. Louis, MOQorannoo 73
- Chicago, ILQorannoo 61
- Baltimore, MDQorannoo 60
- San Antonio, TXQorannoo 59
- Columbus, OHQorannoo 57
- Washington, DCQorannoo 55
Qorannoo biroo Edison keessatti
- Saree OljooQorannoo 68
- Saree (Gosoota Hunda)Qorannoo 33
- Kansarii ProstateQorannoo 29
- Kansarii ColorectalQorannoo 23
- Dhibee QaraQorannoo 23
- Myeloma Baay’eeQorannoo 22
- Dukkana BladderQorannoo 21
- Leukemia Myeloidii HamaaQorannoo 20
- Kansarii OvariiQorannoo 20
- Kansara MetastatikiiQorannoo 20
- Kansa EndometiriyaaliiQorannoo 19
- Kansera Urothelial (Cell Transitional)Qorannoo 18
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.